Mechanisms of inhibition and potentiation of α4β2 nicotinic acetylcholine receptors by members of the Ly6 protein family

Journal of Biological Chemistry

Volumn 290, Issue 40, 2015, Pages 24509-24518

  Wu, Meilin ^a   Puddifoot, Clare A ^a   Taylor, Palmer ^a,b   Joiner, William J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CELL MEMBRANES; ENZYME ACTIVITY; NICOTINE; PROTEINS;

CENTRAL NERVOUS SYSTEMS; CHRONIC EXPOSURE; CIGARETTE SMOKING; INTRACELLULAR TRAFFICKING; NICOTINE ADDICTION; NICOTINIC ACETYLCHOLINE RECEPTORS; NICOTINIC ACETYLCHOLINE RECEPTORS (NACHRS); PHOSPHOLIPASE C;

TOBACCO;

CALCIUM ION; CARRIER PROTEINS AND BINDING PROTEINS; CHAPERONE; LIPID; LY6 PROTEIN; LY6G6E PROTEIN; LYNX2 PROTEIN; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; PHOSPHOLIPASE C; UNCLASSIFIED DRUG; CALCIUM; GREEN FLUORESCENT PROTEIN; LY ANTIGEN; LY6G6E PROTEIN, MOUSE; LYNX2 PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUROPEPTIDE; NICOTINIC AGENT; NICOTINIC RECEPTOR; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DESENSITIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; ANIMAL; BINDING SITE; BIOTINYLATION; CHEMISTRY; HEK293 CELL LINE; HUMAN; METABOLISM; MOUSE; PATCH CLAMP TECHNIQUE; SMOKING;

ALLOSTERIC SITE; ANIMALS; ANTIGENS, LY; BIOTINYLATION; CALCIUM; CELL MEMBRANE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LIPIDS; MEMBRANE GLYCOPROTEINS; MICE; NEUROPEPTIDES; NICOTINE; NICOTINIC AGONISTS; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, NICOTINIC; SMOKING; TYPE C PHOSPHOLIPASES;

EID: 84943328549     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.647248     Document Type: Article

References (58)

1. Gotti, C, Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., and Zoli, M. (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem. Pharmacol. 78, 703-711
2. Conroy, W. G., and Berg, D. K. (1998) Nicotinic receptor subtypes in the developing chick brain: appearance of a species containing the α4, β2, and α5 gene products. Mol. Pharmacol. 53, 392-401
3. Flores, C. M., and Rogers., S. W., Pabreza, L. A., Wolfe, B. B., and Kellar, K. J. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37
4. Whiting, P. J., and Lindstrom, J. M. (1988) Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci. 8, 3395-3404
5. Zoli, M., Léna, C, Picciotto, M. R., and Changeux, J. P. (1998) Identification of four classes of brain nicotinic receptors using β mutant mice. J. Neurosci. 18, 4461-4472
6. Azam, L., Chen, Y., and Leslie, F. M. (2007) Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons. Neuroscience 144, 1347-1360
7. Whiteaker, P., and Cooper., J. F., Salminen, O., Marks, M. J., McClure-Begley, T. D., Brown, R. W. B., Collins, A. C, and Lindstrom, J. M. (2006) Immunolabeling demonstrates the interdependence of mouse brain α4 and β2 nicotinic acetylcholine receptor subunit expression. J. Comp. Neurol. 499, 1016-1038
8. Yang, K., Hu, J., Lucero, L., Liu, Q., Zheng, C, Zhen, X., Jin, G., Lukas, R. J., and Wu, J. (2009) Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. J. Physiol. 587, 345-361
9. Picciotto, M. R., and Addy., N. A., Mineur, Y. S., and Brunzell, D. H. (2008) It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog. Neurobiol. 84, 329-342
10. Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., and Fratta, W. (2008) Crucial role of α4 and α6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J. Neurosci. 28, 12318-12327
11. Benwell, M. E., and Balfour., D. J., and Anderson, J. M. (1988) Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247
12. Breese, C. R., and Marks., M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C, and Leonard, S. (1997) Effect of smoking history on [3H]nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282, 7-13
13. Marks, M. J., and Burch., J. B., and Collins, A. C. (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817-825
14. Perry, D. C, Dávila-García, M. I., Stockmeier, C. A., and Kellar, K. J. (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289, 1545-1552
15. Schwartz, R. D., and Kellar, K. J. (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220, 214-216
16. Lester, H. A., Xiao, C, Srinivasan, R., and Son., C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., and Wang, J. C. (2009) Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J. 11, 167-177
17. Liu, Q., Emadi, S., Shen, J.-X., and Sierks., M. R., and Wu, J. (2013) Human α4β2 nicotinic acetylcholine receptor as a novel target of oligomeric α-synuclein. PLoS ONE 8, e55886
18. Lorenz, R., Samnick, S., Dillmann, U., Schiller, M., and Ong., M. F., Faβbender, K., Buck, A., and Spiegel, J. (2014) Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease. Acta Neurol. Scand. 130, 164-171
19. ∗ nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease. Mol. Pharmacol. 78, 971-980
20. Picciotto, M. R., and Zoli, M. (2008) Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front. Biosci. 13, 492-504
21. Quik, M., Campos, C, Bordia, T., Strachan, J.-P., Zhang, J., and McIntosh., J. M., Letchworth, S., and Jordan, K. (2013) α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats. Neuropharmacology 71, 191-203
22. Quik, M., O'Neill, M., and Perez, X. A. (2007) Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacol. Sci. 28, 229-235
23. Darsow, T., and Booker., T. K., Piña-Crespo, J. C, and Heinemann, S. F. (2005) Exocytic trafficking is required for nicotine-induced up-regulation of α4 β2 nicotinic acetylcholine receptors. J. Biol. Chem. 280, 18311-18320
24. Govind, A. P., Walsh, H., and Green, W. N (2012) Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J. Neurosci. 32, 2227-2238
25. Vallejo, Y. F., Buisson, B., Bertrand, D., and Green, W. N. (2005) Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J. Neurosci. 25, 5563-5572
26. Kuryatov, A., Luo, J., Cooper, J., and Lindstrom, J. (2005) Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol. Pharmacol. 68, 1839-1851
27. Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., and Corringer, P. J. (2005) Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46, 595-607
28. ∗ nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J. Neurosci. 29, 12428-12439
29. Nelson, M. E., Kuryatov, A., Choi, C H., Zhou, Y., and Lindstrom, J. (2003) Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63, 332-341
30. Nichols, W. A., and Henderson., B. J., Yu, C, and Parker., R. L., Richards, C I., Lester, H. A., and Miwa, J. M. (2014) Lynx1 Shifts α4β2 Nicotinic Receptor Subunit Stoichiometry by Affecting Assembly in the Endoplasmic Reticulum. J. Biol. Chem. 289, 31423-31432
31. Adermann, K., Wattler, F., Wattler, S., Heine, G., Meyer, M., Forssmann, W. G., and Nehls, M. (1999) Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPARprotein superfamily. Protein Sci. 8, 810-819
32. Arredondo, J., and Chernyavsky., A. I., Jolkovsky, D. L., Webber, R. J., and Grando, S. A. (2006) SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium. J. Cell. Physiol. 208, 238-245
33. Ibañez-Tallon, I., Miwa, J. M., Wang, H. L., Adams, N. C, Crabtree, G. W., Sine, S. M., and Heintz, N (2002) Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron 33, 893-903
34. Tekinay, A. B., Nong, Y., Miwa, J. M., Lieberam, I., Ibanez-Tallon, I., Greengard, P., and Heintz, N. (2009) A role for LYNX2 in anxiety-related behavior. Proc. Natl. Acad. Sci. U.S.A. 106, 4477-4482
35. Puddifoot, C. A., Wu, M., Sung, R. J., and Joiner, W. J. (2015) Ly6h regulates trafficking of α7 nicotinic acetylcholine receptors and nicotine-induced potentiation of glutamatergic signaling. J. Neurosci. 35, 3420-3430
36. Wu, M., and Robinson., J. E., and Joiner, W. J. (2014) SLEEPLESS Is a Bifunctional Regulator of Excitability and Cholinergic Synaptic Transmission. Curr. Biol. 24, 621-629
37. Yamauchi, J. G., Nemecz, Á., Nguyen, Q. T., Muller, A., Schroeder, L. F., Talley, T. T., Lindstrom, J., Kleinfeld, D., and Taylor, P. (2011) Characterizing ligand-gated ion channel receptors with genetically encoded Ca2+ + sensors. PLoS ONE 6, e16519
38. Wu, M., Li, J., Engleka, K. A., Zhou, B., Lu, M. M., Plotkin, J. B., and Epstein, J. A. (2008) Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice. J. Clin. Invest. 118, 2076-2087
39. Miwa, J. M., and Stevens., T. R., King, S. L., Caldarone, B. J., Ibanez-Tallon, I., Xiao, C, and Fitzsimonds., R. M., Pavlides, C, and Lester., H. A., Picciotto, M. R., and Heintz, N. (2006) The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron 51, 587-600
40. Galat, A., Gross, G., Drevet, P., Sato, A., and Ménez, A. (2008) Conserved structural determinants in three-fingered protein domains. FEBS J 275, 3207-3225
41. Dani, J. A., and Bertrand, D. (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47, 699-729
42. Nashmi, R., and Dickinson., M. E., McKinney, S., Jareb, M., Labarca, C, and Fraser., S. E., and Lester, H. A. (2003) Assembly of α4β2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J. Neurosci. 23, 11554-11567
43. Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., and Lester, H. A. (2011) Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning. J. Gen. Physiol. 137, 59-79
44. Srinivasan, R., and Richards., C. I., Xiao, C, Rhee, D., Pantoja, R., Dougherty, D. A., Miwa, J. M., and Lester, H. A. (2012) Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response. Mol. Pharmacol. 81, 759-769
45. Koh, K., and Joiner., W. J., Wu, M. N, Yue, Z., and Smith., C. J., and Sehgal, A. (2008) Identification of SLEEPLESS, a sleep-promoting factor. Science 321, 372-376
46. Morishita, H., and Miwa., J. M., Heintz, N, and Hensch, T. K. (2010) Lynx1, a cholinergic brake, limits plasticity in adult visual cortex. Science 330, 1238-1240
47. Lyukmanova, E. N, Shenkarev, Z. O., Shulepko, M. A., Mineev, K. S., D'Hoedt, D., Kasheverov, I. E., Filkin, S. Y., Krivolapova, A. P., Janickova, H., Dolezal, V., Dolgikh, D. A., Arseniev, A. S., Bertrand, D., Tsetlin, V. I., and Kirpichnikov, M. P. (2011) NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1. J. Biol. Chem. 286, 10618-10627
48. Auerbach, A., and Akk, G. (1998) Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism. J. Gen. Physiol. 112, 181-197
49. Paradiso, K. G., and Steinbach, J. H. (2003) Nicotine is highly effective at producing desensitization of rat α4β2 neuronal nicotinic receptors. J Physiol 553, 857-871
50. Darvas, M., Morsch, M., Racz, I., Ahmadi, S., Swandulla, D., and Zimmer, A. (2009) Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6. Eur. Neuropsychopharmacol. 19, 670-681
51. Bourne, Y., and Talley., T. T., Hansen, S. B., Taylor, P., and Marchot, P. (2005) Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake α-neurotoxins and nicotinic receptors. EMBO J. 24, 1512-1522
52. Dellisanti, C. D., Yao, Y., Stroud, J. C., Wang, Z.-Z., and Chen, L. (2007) Crystal structure of the extracellular domain of nAChR α1 bound to α-bungarotoxin at 1.94 A resolution. Nat Neurosci. 10, 953-962
53. Huang, S., Li, S.-X., Bren, N, Cheng, K., Gomoto, R., Chen, L., and Sine, S. M. (2013) Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera. Biochem. J. 454, 303-310
54. Tsetlin, V. I. (2015) Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: pharmacological tools and endogenous modulators. Trends Pharmacol. Sci. 36, 109-123
55. Biala, G., Staniak, N, and Budzynska, B. (2010) Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedebergs Arch. Pharmacol. 381, 361-370
56. Coe, J. W., and Brooks., P. R., Vetelino, M. G., Wirtz, M. C, Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., Shrikhande, A., Heym, J. H., Schaeffer, E., Rollema, H, Lu, Y., Mansbach, R. S., Chambers, L. K., Rovetti, C. C, Schulz, D. W., Tingley, F. D., 3rd, and O'Neill, B. T. (2005) Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48, 3474-3477
57. Cohen, C, and Bergis., O. E., Galli, F., Lochead, A. W., Jegham, S., Biton, B., Leonardon, J., Avenet, P., Sgard, F., Besnard, F., Graham, D., Coste, A., Oblin, A., Curet, O., Voltz, C, Gardes, A., Caille, D., Perrault, G., George, P., Soubrie, P., and Scatton, B. (2003) SSR591813, a novel selective and partial α4β2 nicotinic receptor agonist with potential as an aid to smoking cessation. J. Pharmacol. Exp. Ther. 306, 407-420
58. Rollema, H., and Chambers., L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C, Sands, S. B., Schaeffer, E., Schulz, D. W., Tingley, F. D., 3rd, and Williams, K. E. (2007) Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52, 985-994